Yoshinori Shimamoto

Yoshinori Shimamoto

Auto-generated profile, based on publicly available information

Yoshinori Shimamoto

Chiba Neurosurgical Clinic, Chiba, Japan

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 1992 in Leukemia & Lymphoma
Verified
Journal Article
Closed access
PDF file
YSYoshinori Shimamoto
Yoshinori Shimamoto
MYMasaya Yamaguchi
Masaya Yamaguchi
HTLV-I induced not only nodal but also primary extranodal lymphomas. In this report we describe 12 patients with HTLV-I induced extranodal T-cell lymphoma collected from the literature and our institute experience. There were 5 males and 7 female patients of middle age positive for HTLV-1 antibody. The sites of primary tumor were gastrointestinal, Waldeyer's ring, skin, facial sinuses, and the pleura. All of these were histologically diffuse lymphomas and most of them were found to be a helper/inducer T-cell phenotype, showing integration of HTLV-I proviral DNA. Late leukemic changes and skin infiltration often occurred, but hypercalcemia was rare. Survival time varied from 4 to 35 months, and late organ infiltrations were common. These HTLV-I induced extranodal lymphomas were compared with HTLV-I unrelated extranodal lymphomas or HTLV-I induced nodal lymphomas (lymphoma type ATL). Between 1981 and 1990, we had 110 ATL patients and of these, 5 (4.6%) were HTLV-I induced primary extranodal lymphomas. The frequency of HTLV-I induced extranodal lymphoma might be much higher than expected because until now attention has not been paid to this entity. From the present review, it is suggested that HTLV-I could cause primary extranodal lymphoma which may have some different characteristics from other types of lymphoma. Therefore, patients with T-cell extranodal lymphomas should be investigated further for the presence of HTLV-I antibody and the tumor cells should be examined for the integration of HTLV-I proviral DNA using Southern blot analysis. However, this is sometimes difficult to detect with small specimens and in these cases the PCR method for detection of HTLV-I proviral DNA is worthwhile doing. It should be stressed that characterization of a monoclonal T-cell tumoral expansion with the integration of HTLV-I proviral DNA can be done by surface marker studies and gene analysis at the primary sites in patients with T-cell lymphoma and HTLV-I antibody. Further collection of cases with HTLV-I induced primary extranodal lymphoma is necessary in order to elucidate the clinical characteristics of this rare variant of ATL more precisely.

12 September 2017 in Mediators of Inflammation
Verified
Journal Article
Open access
PDF file
HKHiroshi Kitamura
Hiroshi Kitamura
TITakeshi Ishino
Takeshi Ishino
YSYoshinori Shimamoto
Yoshinori Shimamoto
JOJun Okabe
Jun Okabe
TMTomomi Miyamoto
Tomomi Miyamoto
IMIchiro Miyoshi
Ichiro Miyoshi
We investigated the regulatory roles of USP2 in mRNA accumulation of proinflammatory cytokines in macrophage-like cells after stimulation with a toll-like receptor (TLR) 4 ligand, lipopolysaccharide (LPS). Human macrophage-like HL-60 cells, mouse macrophage-like J774.1 cells, and mouse peritoneal macrophages demonstrated negative feedback to USP2 mRNA levels after LPS stimulation, suggesting that USP2 plays a significant role in LPS-stimulated macrophages.USP2knockdown (KD) by short hairpin RNA in HL-60 cells promoted the accumulation of transcripts for 25 of 104 cytokines after LPS stimulation. In contrast, limited induction of cytokines was observed in cells forcibly expressing the longer splice variant of USP2 (USP2A), or in peritoneal macrophages isolated fromUsp2atransgenic mice. An ubiquitin isopeptidase-deficient USP2A mutant failed to suppress LPS-induced cytokine expression, suggesting that protein ubiquitination contributes to USP2-mediated cytokine repression. Although USP2 deficiency did not accelerate TNF receptor-associated factor (TRAF) 6-nuclear factor-κB (NF-κB) signaling, it increased the DNA binding ratio of the octamer binding transcription factor (Oct)-1 to Oct-2 inTNF,CXCL8,CCL4, andIL6promoters. USP2 decreased nuclear Oct-2 protein levels in addition to decreasing the polyubiquitination of Oct-1. In summary, USP2 modulates proinflammatory cytokine induction, possibly through modification of Oct proteins, in macrophages following TLR4 activation.

26 September 2013 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
YSYoshinori Shimamoto
Yoshinori Shimamoto
HKHiroshi Kitamura
Hiroshi Kitamura
KNKimie Niimi
Kimie Niimi
Yasunaga YoshikawaYasunaga Yoshikawa
Yasunaga Yoshikawa
FHFumio Hoshi
Fumio Hoshi
ETEiki Takahashi
Eiki Takahashi

1 January 2012 in Journal of Veterinary Medical Science
Verified
Journal Article
Open access
PDF file
YSYoshinori Shimamoto
Yoshinori Shimamoto
MSMizuki Sasaki
Mizuki Sasaki
HIHiromi Ikadai
Hiromi Ikadai
MIMayumi Ishizuka
Mayumi Ishizuka
NYNaoaki Yokoyama
Naoaki Yokoyama
HKHiroshi Kitamura
Hiroshi Kitamura
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societies

1 January 1996 in Acta Haematologica
Verified
Journal Article
Closed access
PDF file
MMMasaharu Miyahara
Masaharu Miyahara
YSYoshinori Shimamoto
Yoshinori Shimamoto
MSMasayuki Sano
Masayuki Sano
HNHiroko Nakano
Hiroko Nakano
KSKeisuke Shibata
Keisuke Shibata
MMMiwako Matsuzaki
Miwako Matsuzaki
Pleural effusion in chronic lymphocytic leukemia (CLL) is a relatively rare phenomenon. We report a case of a pleural effusion associated with B-cell CLL but with predominantly reactive T lymphocytes in the effusion. A cell surface phenotype study showed that T lymphocytes predominated in the pleural effusion, although B lymphocytes were predominant in the peripheral blood. Genotypic analysis of the cells in the peripheral blood, bone marrow, lymph node, and pleural effusion showed the same rearrangement pattern of the immunoglobulin heavy chain genes consistent with a B-lymphocytic neoplasm (CLL). A pleural biopsy demonstrated diffuse infiltration of lymphoid cells. Most of the cells demonstrated T cell markers, although some cells revealed B cell markers by immunologic staining. These results suggested that the pleural involvement by B-CLL may have caused a reactive T-lymphocyte proliferation in the pleura and pleural effusion. To our knowledge, this is the first published case indicating that genotypic analysis of immunoglobulin heavy chain gene rearrangement may be useful in the diagnosis of a pleural effusion associated with B-cell CLL.

1 January 2021 in Journal of Dental Anesthesia and Pain Medicine
Verified
Journal Article
Open access
PDF file
TNTomoyasu Noguchi
Tomoyasu Noguchi
YSYoshinori Shimamoto
Yoshinori Shimamoto
KFKenichi Fukuda
Kenichi Fukuda
Noguchi T, et al. J Dent Anesth Pain Med. 2021 Oct;21(5):431-440. https://doi.org/10.17245/jdapm.2021.21.5.431